Data Driven Behavior Intervention and Medical Outcome Evaluation of Patients' Comprehensive Monitoring
1 other identifier
observational
1,000
0 countries
N/A
Brief Summary
During the study, the resuscitation room, general wards and ICU were installed fixed or mobile acquisition devices in the resuscitation room, the emergency department of Peking Union Medical College Hospital, and the collection platform was set up. Patients with acute diseases (infection, diabetes complications, etc.) caused by metabolic syndrome (obesity, diabetes, etc.) were selected after informed consent. All medical intervention behaviors, relevant medical records and medical outcome records within the collection scope of the device platform were collected prospectively . And regular follow-up, guidance of patients with metabolic syndrome control, while collecting all the lifestyle characteristics of patients, some patients with metabolic cabin research, and observe the relevant medical outcomes. After that, all the collected data were coded, and the influence of all lifestyle and medical behavior interventions on patients' medical outcomes was studied by artificial intelligence method.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2021
Typical duration for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 8, 2021
CompletedFirst Posted
Study publicly available on registry
July 19, 2021
CompletedStudy Start
First participant enrolled
August 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2023
CompletedJuly 27, 2021
July 1, 2021
2.3 years
July 8, 2021
July 20, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Rate of metabolic complications
Relapse of acute metabolic disease, stability of biochemical metabolic indexes (such as glycosylated hemoglobin, BMI)
6 weeks
Complication control
The occurrence of metabolic complications, infection and cardiovascular events
3 weeks
Rate of mortality
30-day and 90-day mortality. Death due to cardiovascualr complications
6 months
Secondary Outcomes (2)
Total cost of treatment
3 weeks
Quality of life
6 months
Eligibility Criteria
Patients with metabolic syndrome (obesity, diabetes, etc.) cause acute disease attacks (infection, diabetes complications, etc.).
You may qualify if:
- Diabetes and / or obesity (BMI\>=28).
- Emergency room / emergency ward / EICU;
- Be able to understand and agree the research protocol and sign the informed consent
You may not qualify if:
- Pregnant women / lactation period;
- The estimated survival time was less than 1 year;
- Long term follow-up is not guaranteed;
- Failure to comply with the protocol or procedure;
- The collection of medical behavior data can not complete the de privacy or label after de privacy;
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Peking Union Medical College Hospitallead
- Peking Universitycollaborator
- Guangdong Provincial People's Hospitalcollaborator
- Guangzhou Huyun Hospital Management Co., Ltdcollaborator
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 8, 2021
First Posted
July 19, 2021
Study Start
August 1, 2021
Primary Completion
November 30, 2023
Study Completion
November 30, 2023
Last Updated
July 27, 2021
Record last verified: 2021-07